October 28, 2015November 9, 2015

Boehringer’s STIOLTO RESPIMAT Shows Promising Results Clinical Trials

COPD, News

Post-hoc analysis of the TONADO and OTEMTO trials of the 15,000-patient phase III Chronic Obstructive Pulmonary Disease (COPD) clinical trial TOviTO assessing Boehringer Ingelheim‘s STIOLTO RESPIMAT’s efficacy and safety in COPD were recently ... Read more

May 21, 2015November 9, 2015

Boehringer’s Drug Combination Therapy For COPD Promotes Lung Function Improvement in Patients

COPD, News

Boehringer Ingelheim Pharmaceuticals, Inc. recently announced new data from the pivotal Phase III TONADO™ 1&2 studies (NCT01431274 and NCT01431287), regarding the efficacy and safety of its investigational product tiotropium/olodaterol delivered via ... Read more